The Impact of Donor Type on Long-Term Health Status and Quality of Life after Allogeneic Hematopoietic Stem Cell Transplantation for Childhood Acute Leukemia: A Leucemie de l'Enfant et de L'Adolescent Study - Université de Rennes Access content directly
Journal Articles Biology of Blood and Marrow Transplantation Year : 2016

The Impact of Donor Type on Long-Term Health Status and Quality of Life after Allogeneic Hematopoietic Stem Cell Transplantation for Childhood Acute Leukemia: A Leucemie de l'Enfant et de L'Adolescent Study

Yves Bertrand
  • Function : Author
  • PersonId : 899520
Claire Freycon
  • Function : Author
Jean-Hugues Dalle

Abstract

We compared the long-term impact of donor type (sibling donor [SD] versus matched unrelated donor [MUD] or umbilical cord blood [UCB]) on late side effects and quality of life (QoL) in childhood acute leukemia survivors treated with hematopoietic stem cell transplantation. We included 314 patients who underwent transplantation from 1997 to 2012 and were enrolled in the multicenter French Leucemie de l'Enfant et de L'Adolescent ("Leukemia in Children and Adolescents") cohort. More than one-third of the patients were adults at last visit; mean follow-up duration was 6.2 years. At least 1 late effect was observed in 284 of 314 patients (90.4%). The average number of adverse late effects was 2.1 +/- 1, 2.4 +/- 2, and 2.4 +/- 2 after SD, MUD, and UCB transplantation, respectively. In a multivariate analysis, considering the SD group as the reference, we did not detect an impact of donor type for most sequelae, with the exception of increased risk of major growth failure after MUD transplantation (odds ratio [OR], 2.42) and elevated risk of osteonecrosis after UCB transplantation (OR, 4.15). The adults and children's parents reported comparable QoL among the 3 groups. Adult patient QoL scores were lower than age- and sex-matched French reference scores for almost all dimensions. We conclude that although these patients are heavily burdened by long-term complications, donor type had a very limited impact on their long-term health status and QoL.
Fichier principal
Vignette du fichier
The Impact of Donor Type on Long-Term.pdf (223.73 Ko) Télécharger le fichier
1-s2.0-S1083879116302798-mmc1.d.pdf (28.41 Ko) Télécharger le fichier
Origin : Files produced by the author(s)

Dates and versions

hal-01415935 , version 1 (28-03-2018)

Identifiers

Cite

Sandrine Visentin, Pascal Auquier, Yves Bertrand, André Baruchel, Marie-Dominique Tabone, et al.. The Impact of Donor Type on Long-Term Health Status and Quality of Life after Allogeneic Hematopoietic Stem Cell Transplantation for Childhood Acute Leukemia: A Leucemie de l'Enfant et de L'Adolescent Study. Biology of Blood and Marrow Transplantation, 2016, 22 (11), pp.2003--2010. ⟨10.1016/j.bbmt.2016.08.004⟩. ⟨hal-01415935⟩
593 View
289 Download

Altmetric

Share

Gmail Facebook X LinkedIn More